In recent years, new drugs called “biosimilars” have become available in the United States, and in the summer of 2023 at least eight new competitors to adalimumab (Humira) will be introduced. This article from the Arthritis Foundation explains how these new biologic drugs compare with existing ones, and addresses whether biosimilars should be taken during pregnancy or breastfeeding.
Mariah is a writer, patient advocate, and mom of three living with rheumatoid arthritis and Hashimoto’s thyroiditis. After learning firsthand how challenging and lonely it can be to face pregnancy and parenthood with chronic illness, Mariah became passionate about supporting people with chronic illness who are or want to become parents. She launched her private Facebook support group, Mamas Facing Forward, in 2015. Today the group connects parents and parents-to-be with chronic illness from all over the world. In 2018, she added this website, dedicated to collecting and creating resources that focus on pregnancy and parenting with chronic illness.
